Quantum Hi-Tech (China) Biotechnology Co., Ltd, known as ChemPartner (SHE: 300149), is poised to raise a significant amount of capital through a private share placement. The company plans to issue 149,389,197 shares at a price of RMB 6.23 per share, which is expected to yield over RMB 930 million (USD 128 million).
ChemPartner’s Strategy to Enhance Core Competitiveness
ChemPartner, a global provider of drug discovery, development, and production services to pharmaceutical and biotechnology companies as well as research institutions, intends to use the proceeds from this private placement to enhance its core competitiveness and operational capabilities. The funds raised will be instrumental in strengthening the company’s position in the CRO+CDMO sector.
The Impact of the Capital Increase on ChemPartner’s Operations
The capital increase will provide ChemPartner with the resources necessary to expand its service offerings, improve existing processes, and invest in cutting-edge technologies. This strategic move is expected to bolster the company’s ability to serve its clients more effectively and to pursue new opportunities in the rapidly evolving pharmaceutical and biotech industries.-Fineline Info & Tech
